Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Maidimeisu
2. Midecamin
3. Midecamycin
4. Midecamycin Diacetate
5. Midekamycin
6. Midekamycin Acetate
7. Mosil
8. Mydecamycin
9. Myoxam
10. Neoisomidecamycin
11. Normicina
12. Sf 837
13. Sf-837
1. Miocamycin
2. Acecamycin
3. Miokamycin
4. Ponsinomycin
5. 3'',9-diacetylmydecamycin
6. 55881-07-7
7. Midecamycin Acetate [jan]
8. Midecamycin Diacetate
9. 9,3''-di-o-acetylmidecamycin
10. Leucomycin V, 3b,9-diacetate 3,4b-dipropanoate
11. 3t48cps7u2
12. Mom
13. [(4r,5s,6s,7r,9r,10r,11e,13e,16r)-10-acetyloxy-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4-acetyloxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] Propanoate
14. 9,3''-diacetylmidecamycin
15. Einecs 259-879-6
16. Unii-3t48cps7u2
17. Macroral
18. Miocamen
19. Mosil
20. Miocamycin (tn)
21. Miocamycin [mi]
22. Midecamycin Acetate (jp17)
23. Schembl139293
24. Chembl1091024
25. Dtxsid60905087
26. Leucomycin V, 3(sup B),9-diacetate 3,4(sup B)-dipropanoate
27. Midecamycin Acetate [who-dd]
28. Zinc169677000
29. 1532-rb
30. Leucomycinv,3b,9-diacetate3,4b-dipropanoate
31. D01636
32. Q3858659
33. W-105540
34. Midecamycin Acetate, Antibiotic For Culture Media Use Only
| Molecular Weight | 898.0 g/mol |
|---|---|
| Molecular Formula | C45H71NO17 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 18 |
| Exact Mass | 897.47219980 g/mol |
| Monoisotopic Mass | 897.47219980 g/mol |
| Topological Polar Surface Area | 218 Ų |
| Heavy Atom Count | 63 |
| Formal Charge | 0 |
| Complexity | 1590 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 16 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01F - Macrolides, lincosamides and streptogramins
J01FA - Macrolides
J01FA11 - Miocamycin
Global Sales Information
Market Place
ABOUT THIS PAGE
A Miocamycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Miocamycin, including repackagers and relabelers. The FDA regulates Miocamycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Miocamycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Miocamycin supplier is an individual or a company that provides Miocamycin active pharmaceutical ingredient (API) or Miocamycin finished formulations upon request. The Miocamycin suppliers may include Miocamycin API manufacturers, exporters, distributors and traders.
Miocamycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Miocamycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Miocamycin GMP manufacturer or Miocamycin GMP API supplier for your needs.
A Miocamycin CoA (Certificate of Analysis) is a formal document that attests to Miocamycin's compliance with Miocamycin specifications and serves as a tool for batch-level quality control.
Miocamycin CoA mostly includes findings from lab analyses of a specific batch. For each Miocamycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Miocamycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Miocamycin EP), Miocamycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Miocamycin USP).
LOOKING FOR A SUPPLIER?
